NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE273572 Query DataSets for GSE273572
Status Public on Jul 31, 2024
Title JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia (scRNA-seq)
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Summary The hair follicle stem cell niche is an immune-privileged microenvironment, characterized by reduced antigen presentation, thus shielding against permanent immune-mediated tissue damage. In this study, we demonstrated the protective role of hair follicle-specific epidermal growth factor receptor (EGFR) against scarring hair follicle destruction. Mechanistically, disruption of EGFR signalling generated a cell-intrinsic hypersensitivity within the JAK-STAT1 pathway, which, synergistically with interferon gamma expressing CD8 T-cell and NK-cell-mediated inflammation, compromised the stem cell niche. Hair follicle-specific genetic depletion of either JAK1/2 or STAT1 or therapeutic inhibition of JAK1/2 ameliorated the inflammation, restored skin barrier function and activated the residual stem cells to resume hair growth in mouse models of epidermal and hair follicle-specific EGFR deletion. Skin biopsies from EGFR inhibitor-treated and cicatricial alopecia patients indicated active STAT1 signalling and interferon target expression. Notably, a case study of folliculitis decalvans, characterized by progressive hair loss, scaling and perifollicular erythema, demonstrated successful treatment with JAK1/2 inhibition. Our findings offer molecular insights and present a mechanism-based therapeutic strategy for addressing chronic folliculitis associated with EGFR-inhibitor anti-cancer therapy and cicatricial alopecia.
 
Overall design In order to expand the depth of the immunological analysis, we performed single-cell RNA sequencing of the hair follicle and immune cell compartment of 4 EGFRdeltaEgr2 mice at 3 months of age.
 
Contributor(s) Strobl K, Jin R, Bauer T
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Jul 31, 2024
Last update date Aug 01, 2024
Contact name Thomas Bauer
E-mail(s) thomas.bauer@meduniwien.ac.at
Organization name Medical University of Vienna
Department Center for Cancer Research
Lab Bauer Lab
Street address Borschkegasse 8A
City Vienna
State/province Vienna
ZIP/Postal code 1090
Country Austria
 
Platforms (1)
GPL24247 Illumina NovaSeq 6000 (Mus musculus)
Samples (1)
GSM8432472 Epidermis, Egfr-floxed Egr2-Cre, 4 reps pooled, scRNA-seq
Relations
BioProject PRJNA1142442

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE273572_RAW.tar 109.5 Mb (http)(custom) TAR (of MTX, TSV)
SRA Run SelectorHelp
Raw data are available in SRA

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap